Van professionele vertalers, bedrijven, webpagina's en gratis beschikbare vertaalbronnen.
príhovor spolkového kancelára helmuta kohla na inauguračnom ceremoniáli v alte oper vo frankfurte nad mohanom 30. júna 1998
german chancellor helmut kohl giving a speech at the inauguration ceremony at the alte oper frankfurt on 30 june 1998
príhovor prezidenta ecb willema f. duisenberga na inauguračnom ceremoniáli v alte oper vo frankfurte nad mohanom 30. júna 1998
president duisenberg speaking at the inauguration ceremony at the alte oper frankfurt on 30 june 1998
prezident trichet sfúkava sviečky na narodeninovej torte pri príležitosti osláv 10 . výročia ecb v alte oper vo frankfurte nad mohanom 2 .
president trichet blowing out the candles on the birthday cake at the 10th anniversary of the ecb at the alte oper frankfurt on 2 june 2008 .
príhovor predsedu európskej komisie josého manuela barrosu na slávnostnom ceremoniáli pri príležitosti osláv 10 . výročia ecb v alte oper vo frankfurte nad mohanom 2 .
josé manuel barroso , president of the european commission , speaking at the ceremony to mark the 10th anniversary of the ecb at the alte oper frankfurt on 2 june 2008
gretta duisenbergová, prezident ecb willem f. duisenberg a spolkový kancelár helmut kohl pred inauguračným ceremoniálom v alte oper vo frankfurte nad mohanom 30. júna 1998
gretta duisenberg, president duisenberg and german chancellor helmut kohl before the inauguration ceremony at the alte oper frankfurt on 30 june 1998
doza uzuală de reyataz capsule la adulţi este de 300 mg o dată pe zi cu 100 mg ritonavir o dată pe zi şi cu alimente, în asociere cu alte medicamente anti- hiv.
the usual adult dose of reyataz capsules is 300 mg once daily with 100 mg ritonavir once daily and with food, in combination with other anti-hiv medicines.
În timp ce poate contribui la scăderea sensibilităţii la atazanavir, dacă survine în asociere cu alte substituţii la nivelul proteazei, în studiile clinice, n88s singură nu duce la rezistenţă fenotipică la atazanavir sau nu are un impact constant asupra eficacităţii clinice.
while it may contribute to decreased susceptibility to atazanavir when it occurs with other protease substitutions, in clinical studies n88s by itself does not lead to phenotypic resistance to atazanavir or have a consistent impact on clinical efficacy.